Kai von Dickhoff

449 total citations
16 papers, 352 citations indexed

About

Kai von Dickhoff is a scholar working on Ophthalmology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Kai von Dickhoff has authored 16 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Ophthalmology, 7 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Physiology. Recurrent topics in Kai von Dickhoff's work include Retinal Diseases and Treatments (5 papers), Pain Mechanisms and Treatments (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Kai von Dickhoff is often cited by papers focused on Retinal Diseases and Treatments (5 papers), Pain Mechanisms and Treatments (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Kai von Dickhoff collaborates with scholars based in Finland, Sweden and United Kingdom. Kai von Dickhoff's co-authors include Olavi Ukkola, Pasi Salmela, Leila Laatikainen, Y. Antero Kesäniemi, Markku J. Savolainen, Kari Kervinen, Markku Laakso, Taina Turpeenniemi‐Hujanen, Matti Kallioinen and Olli Oksala and has published in prestigious journals such as The Journal of Pathology, Atherosclerosis and Experimental Eye Research.

In The Last Decade

Kai von Dickhoff

16 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai von Dickhoff Finland 11 122 118 92 60 58 16 352
Carin Gustavsson Sweden 10 59 0.5× 212 1.8× 44 0.5× 107 1.8× 39 0.7× 15 476
Can Pang China 9 97 0.8× 87 0.7× 67 0.7× 71 1.2× 70 1.2× 14 414
JJ Mullins United Kingdom 8 94 0.8× 125 1.1× 24 0.3× 180 3.0× 129 2.2× 16 409
Amirfarbod Yazdanyar United States 10 50 0.4× 91 0.8× 73 0.8× 141 2.4× 20 0.3× 17 298
Irene Andrés‐Blasco Spain 9 115 0.9× 38 0.3× 85 0.9× 120 2.0× 35 0.6× 17 348
Hongwei Yang China 10 31 0.3× 92 0.8× 75 0.8× 186 3.1× 34 0.6× 24 404
Dalia Žaliūnienė Lithuania 10 65 0.5× 187 1.6× 42 0.5× 82 1.4× 16 0.3× 54 351
Irene Fornaciari Italy 10 54 0.4× 49 0.4× 31 0.3× 89 1.5× 17 0.3× 12 321
Alvita Vilkevičiūtė Lithuania 10 57 0.5× 114 1.0× 31 0.3× 122 2.0× 6 0.1× 67 348
Huanran Zhou China 9 90 0.7× 57 0.5× 57 0.6× 217 3.6× 17 0.3× 12 397

Countries citing papers authored by Kai von Dickhoff

Since Specialization
Citations

This map shows the geographic impact of Kai von Dickhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai von Dickhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai von Dickhoff more than expected).

Fields of papers citing papers by Kai von Dickhoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai von Dickhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai von Dickhoff. The network helps show where Kai von Dickhoff may publish in the future.

Co-authorship network of co-authors of Kai von Dickhoff

This figure shows the co-authorship network connecting the top 25 collaborators of Kai von Dickhoff. A scholar is included among the top collaborators of Kai von Dickhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai von Dickhoff. Kai von Dickhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Kallioinen, Matti, et al.. (1999). Matrix metalloproteinase-2 (MMP-2) immunoreactive protein?a new prognostic marker in uveal melanoma?. The Journal of Pathology. 188(1). 56–62. 72 indexed citations
2.
Väisänen, Anne, Matti Kallioinen, Kai von Dickhoff, et al.. (1999). Matrix metalloproteinase‐2 (MMP‐2) immunoreactive protein—a new prognostic marker in uveal melanoma?. The Journal of Pathology. 188(1). 56–62. 1 indexed citations
3.
Krootila, Kari, Olli Oksala, Kai von Dickhoff, Arto Palkama, & Hannu Uusitalo. (1995). Effect of Captopril on Ocular Irritative Response to Topical Neutral Formaldehyde and Yag-Laser Capsulotomy in the Rabbit. Journal of Ocular Pharmacology and Therapeutics. 11(3). 243–252. 5 indexed citations
4.
5.
Ukkola, Olavi, Markku J. Savolainen, Pasi Salmela, et al.. (1995). Insertion/deletion polymorphism in the angiotensin-converting enzyme gene associated with macroangiopathy and blood pressure in patients with non-insulin-dependent diabetes mellitus. Journal of Molecular Medicine. 73(6). 307–311. 12 indexed citations
6.
Koskela, Pentti, Leila Laatikainen, & Kai von Dickhoff. (1994). Contrast sensitivity after resolution of central serous retinopathy. Graefe s Archive for Clinical and Experimental Ophthalmology. 232(8). 473–476. 21 indexed citations
7.
Kokkonen, Jorma, et al.. (1994). Ocular complications in young adults with insulin‐dependent diabetes mellitus since childhood. Acta Paediatrica. 83(3). 273–278. 16 indexed citations
8.
Ukkola, Olavi, Markku J. Savolainen, Pasi Salmela, Kai von Dickhoff, & Y. Antero Kesäniemi. (1994). DNA polymorphisms at the locus for human cholesteryl ester transfer protein (CETP) are associated with macro‐ and microangiopathy in non‐insulin‐dependent diabetes mellitus. Clinical Genetics. 46(3). 217–227. 19 indexed citations
9.
Ukkola, Olavi, Markku J. Savolainen, Pasi Salmela, Kai von Dickhoff, & Y. Antero Kesäniemi. (1993). Apolipoprotein B gene DNA polymorphisms are associated with macro‐ and microangiopathy in non‐insulin‐dependent diabetes mellitus. Clinical Genetics. 44(4). 177–184. 24 indexed citations
10.
Ukkola, Olavi, Kari Kervinen, Pasi Salmela, et al.. (1993). Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus. Atherosclerosis. 101(1). 9–15. 76 indexed citations
11.
Krootila, Kari, Olli Oksala, Kai von Dickhoff, et al.. (1992). Ocular irritative response to YAG laser capsulotomy in rabbits: Release of calcitonin gene-related peptide and effects of methysergide. Current Eye Research. 11(4). 307–314. 4 indexed citations
12.
Dickhoff, Kai von, et al.. (1989). [Retinal pigment epithelial changes related to central serous retinopathy].. PubMed. 12(12). 877–81. 8 indexed citations
13.
Oksala, Olli, Johan Stjernschantz, & Kai von Dickhoff. (1989). Characterization of the Mechanism of Acute Ocular Irritation to YAG Laser Capsulotomy in Rabbits: Effects of Substance P Antagonists, Met-Enkephalin, Tetracaine and Tetrodotoxin. Ophthalmic Research. 21(5). 360–368. 7 indexed citations
14.
Stjernschantz, Johan, Kai von Dickhoff, Olli Oksala, & Heikki Seppä. (1986). A study of the mechanism of ocular irritation following YAG laser capsulotomy in rabbits. Experimental Eye Research. 43(4). 641–651. 16 indexed citations
15.
Algvere, Peep V., et al.. (1981). PARS PLANA VITRECTOMY IN THE MANAGEMENT OF INTRAOCULAR INFLAMMATION. Acta Ophthalmologica. 59(5). 727–736. 29 indexed citations
16.
Ahvonen, P & Kai von Dickhoff. (1974). Uveitis, episcleritis and conjunctivitis associated with Yersinia infection.. PubMed. 123. 209–12. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026